Evidence map›Paper›PMID 38740751›Full record

ArticleNature communications2024

Mammographic density mediates the protective effect of early-life body size on breast cancer risk.

Marina Vabistsevits, George Davey Smith, Tom G Richardson, Rebecca C Richmond, Weiva Sieh, Joseph H Rothstein, Laurel A Habel, Stacey E Alexeeff, Bethan Lloyd-Lewis, Eleanor Sanderson

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Marina VabistsevitsUniversity of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK. marina.vabistsevits@bristol.ac.uk.ORCID http://orcid.org/0000-0003-1121-6790
George Davey SmithUniversity of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK.ORCID http://orcid.org/0000-0002-1407-8314
Tom G RichardsonUniversity of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK.ORCID http://orcid.org/0000-0002-7918-2040
Rebecca C RichmondUniversity of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK.ORCID http://orcid.org/0000-0003-0574-5071
Weiva SiehIcahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, Department of Population Health Science and Policy, New York, NY, USA.ORCID http://orcid.org/0000-0003-0085-1190
Joseph H RothsteinIcahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, Department of Population Health Science and Policy, New York, NY, USA.
Laurel A HabelKaiser Permanente Northern California, Division of Research, Oakland, CA, USA.
Stacey E AlexeeffKaiser Permanente Northern California, Division of Research, Oakland, CA, USA.
Bethan Lloyd-Lewis *University of Bristol, School of Cellular and Molecular Medicine, Bristol, UK.ORCID http://orcid.org/0000-0001-6511-1818
Eleanor Sanderson *University of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK.ORCID http://orcid.org/0000-0001-5188-5775

Funding

Radiomic and genomic predictors of breast cancer riskR01CA264987 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Vignesh A Arasu, Li Shen · 2021 to 2026
$3.5M
Genome-Wide Association Study of Mammographic DensityR01CA166827 · NCI · STANFORD UNIVERSITY · PI HABEL, LAUREL A, SIEH, WEIVA · 2012 to 2016
$2.3M
Genomic and Transcriptomic Analysis of Mammographic DensityR01CA237541 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HABEL, LAUREL A, SIEH, WEIVA · 2020 to 2023
$2.0M
Cancer Research UK 29019Medical Research Council MC_UU_00032/1NCI NIH HHS R01 CA166827NCI NIH HHS R01 CA237541NCI NIH HHS R01 CA264987RCUK | Medical Research Council (MRC) MC_UU_00032/01Wellcome Trust
6 · The paper itself

Abstract

The unexplained protective effect of childhood adiposity on breast cancer risk may be mediated via mammographic density (MD). Here, we investigate a complex relationship between adiposity in childhood and adulthood, puberty onset, MD phenotypes (dense area (DA), non-dense area (NDA), percent density (PD)), and their effects on breast cancer. We use Mendelian randomization (MR) and multivariable MR to estimate the total and direct effects of adiposity and age at menarche on MD phenotypes. Childhood adiposity has a decreasing effect on DA, while adulthood adiposity increases NDA. Later menarche increases DA/PD, but when accounting for childhood adiposity, this effect is attenuated. Next, we examine the effect of MD on breast cancer risk. DA/PD have a risk-increasing effect on breast cancer across all subtypes. The MD SNPs estimates are heterogeneous, and additional analyses suggest that different mechanisms may be linking MD and breast cancer. Finally, we evaluate the role of MD in the protective effect of childhood adiposity on breast cancer. Mediation MR analysis shows that 56% (95% CIs [32%-79%]) of this effect is mediated via DA. Our finding suggests that higher childhood adiposity decreases mammographic DA, subsequently reducing breast cancer risk. Understanding this mechanism is important for identifying potential intervention targets.

Indexed as

AdiposityBreast DensityBreast NeoplasmsMammographyMenarcheMendelian Randomization AnalysisAdultBody SizeChildFemaleHumansMiddle AgedPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID38740751
PMCPMC11091136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.